Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 785† | 660† | — | 548† | 584† |
| Net profit | 99 | 53 | 30 | 29 | 49† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| AKSHANSH CHAUDHARY | Executive Director | June 30, 2026 |
| ASHUTOSH JAIN | Executive Director | June 30, 2026 |
| MANU CHAUDHARY | Executive Director | June 30, 2026 |
| PAWAN CHAUDHARY | Executive Director | June 30, 2026 |
| PEEYUSH JAIN | Executive Director | June 30, 2026 |
| SARANSH CHAUDHARY | Executive Director | June 30, 2026 |
| ANIL KUMAR | Independent Director | June 30, 2026 |
| GURMINDER SINGH BEDI | Independent Director | June 30, 2026 |
| JAGDISH CHANDER SHARMA | Independent Director | June 30, 2026 |
| NAVDEEP SUD | Independent Director | June 30, 2026 |
| NPS MONGA | Independent Director | June 30, 2026 |
| SAVITA GUPTA | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
